Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Events, News and Seminars

Common medication may lower risk of “heartbreak”

Common medication may lower risk of “heartbreak”

RNSH cardiologist Professor Geoffrey Tofler has led a world-first study which found that common med..... Read more

Category: Research Excellence

Research spotlight on specialist NICU team

Research spotlight on specialist NICU team

Celebrity couple Hayden James and Jennifer Luby shared their emotional journey following the premat..... Read more

Category: Research Excellence

Newsletter

Newsletter

Read more

Category: Newsletters